Case report

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Mao S, Zhang J, Guo Y, Zhang Z, Wu Y, Zhang W, Wang L, Jiang Geng, Yan Y, Yao X

Drug Design, Development and Therapy 2019, 13:291-300

Published Date: 11 January 2019